Trials of potential treatments for both early and late-onset Alzheimer’s diseases are among seven projects to receive $45 million in new funding from the National Institutes of Health as part of a US effort to accelerate research into the disease. ---Subscribe to MedNous to access this article--- Research & University News Clinical Research
